Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
Cancer Epidemiol. 2022 Aug;79:102194. doi: 10.1016/j.canep.2022.102194. Epub 2022 Jun 7.
Adults with high-risk smoking histories benefit from annual lung cancer screening. It is unclear if there is an association between lung cancer screening and smoking cessation among U.S. adults who receive screening.
We performed this population-based cross-sectional study using data from the Behavioral Risk Factor Surveillance System (2017-2020). We defined individuals eligible for lung cancer screening as adults 55-80 years old with ≥ 30 pack-year smoking history who were currently smoking or quit within the last 15 years. We assessed the association between lung cancer screening and current smoking status.
Between 2017 and 2020, 12,382 participants met screening criteria. Current smoking was reported by 5685 (45.9 %) participants, of whom 40.4 % (2298) reported a cessation attempt in the prior year. Lung cancer screening was reported by only 2022 (16.3 %) eligible participants. Lung cancer screening was associated with lower likelihood of currently smoking (odds ratio [OR] 0.705, 95 % CI 0.626-0.793) compared to individuals who did not receive screening. Screening was also associated with higher likelihood of reporting a cessation attempt in the prior year (OR 1.562, 95 % CI 1.345-1.815) compared to individuals who did not receive screening.
Receipt of lung cancer screening was associated with lower smoking rates and more frequent cessation attempts among U.S. adults. Better implementation of lung cancer screening programs is critical and may profoundly increase smoking cessation in this population at risk of developing lung cancer.
有高危吸烟史的成年人受益于每年的肺癌筛查。目前尚不清楚在美国接受筛查的成年人中，肺癌筛查与戒烟之间是否存在关联。
我们使用行为风险因素监测系统（2017-2020 年）的数据进行了这项基于人群的横断面研究。我们将有资格进行肺癌筛查的个体定义为年龄在 55-80 岁之间、有≥30 包年吸烟史、目前吸烟或在过去 15 年内戒烟的成年人。我们评估了肺癌筛查与当前吸烟状况之间的关联。
在 2017 年至 2020 年间，有 12382 名参与者符合筛查标准。有 5685 名（45.9%）参与者报告目前吸烟，其中 40.4%（2298 名）报告在过去一年中有戒烟尝试。只有 2022 名（16.3%）符合条件的参与者接受了肺癌筛查。与未接受筛查的参与者相比，肺癌筛查与较低的当前吸烟可能性相关（比值比 [OR] 0.705，95%CI 0.626-0.793）。与未接受筛查的参与者相比，筛查还与更高的过去一年中有戒烟尝试的可能性相关（OR 1.562，95%CI 1.345-1.815）。
在美国成年人中，接受肺癌筛查与较低的吸烟率和更频繁的戒烟尝试有关。更好地实施肺癌筛查计划至关重要，可能会极大地增加该人群中罹患肺癌的风险的戒烟率。
